FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313522493> ?p ?o ?g. }

• W4313522493 abstract "Abstract Background Although the promising advancements of current therapeutic approaches is available for the squamous cell carcinoma (SCC) patients, the clinical treatment of SCC still faces many difficulties. The surgical irreparable disfigurement and the postoperative wound infection largely hamper the recovery, and the chemo/radiotherapy leads to toxic side effects. Results Herein, a novel pH/Hyaluronidase (HAase) dual-stimuli triggered smart nanoprobe Fe III TA@HA has been designed through the biomineralization of Fe 3+ and polyphenol tannic acid (TA) under the control of hyaluronic acid (HA) matrix. With the HA residues on the outer surface, Fe III TA@HA nanoprobes can specifically target the SCC cells through the over-expressed CD44, and accumulate in the carcinoma region after intravenously administration. The abundant HAase in carcinoma microenvironment will trigger the degradation of HA molecules, thereby exposing the Fe III TA complex. After ingesting by tumor cells via CD44 mediated endocytosis, the acidic lysosomal condition will further trigger the protonation of TA molecules, finally leading to the Fe 3+ release of nanoprobe, and inducing a hybrid ferroptosis/apoptosis of tumor cells through peroxidase activity and glutathione depletion. In addition, Owing to the outstanding T 1 magnetic resonance imaging (MRI) performance and phototermal conversion efficiency of nanoprobes, the MRI-guided photothermal therapy (PTT) can be also combined to complement the Fe 3+ -induced cancer therapy. Meanwhile, it was also found that the nanoprobes can promote the recruitment of CD4 + and CD8 + T cells to inhibit the tumor growth through the cytokines secretion. In addition, the Fe III TA@HA nanoprobes can be eliminated from the body and no obvious adverse side effect can be found in histological analysis, which confirmed the biosafety of them. Conclusion The current Fe III TA@HA nanoprobe has huge potential in clinical translation in the field of precise diagnosis and intelligent synergistic therapy of superficial SCC. This strategy will promisingly avoid the surgical defects, and reduce the systemic side effect of traditional chemotherapy, paving a new way for the future SCC treatment. Graphical Abstract" @default.
• W4313522493 created "2023-01-06" @default.
• W4313522493 creator A5001154049 @default.
• W4313522493 creator A5003559708 @default.
• W4313522493 creator A5005054655 @default.
• W4313522493 creator A5005792080 @default.
• W4313522493 creator A5007788604 @default.
• W4313522493 creator A5011272577 @default.
• W4313522493 creator A5024942897 @default.
• W4313522493 creator A5025085123 @default.
• W4313522493 creator A5033334352 @default.
• W4313522493 creator A5064008773 @default.
• W4313522493 creator A5070917604 @default.
• W4313522493 creator A5078841336 @default.
• W4313522493 creator A5082093262 @default.
• W4313522493 creator A5083397911 @default.
• W4313522493 creator A5084685429 @default.
• W4313522493 date "2023-01-03" @default.
• W4313522493 modified "2023-10-17" @default.
• W4313522493 title "Dual-stimuli responsive smart nanoprobe for precise diagnosis and synergistic multi-modalities therapy of superficial squamous cell carcinoma" @default.
• W4313522493 cites W1488908620 @default.
• W4313522493 cites W1968771883 @default.
• W4313522493 cites W1987893498 @default.
• W4313522493 cites W2032025349 @default.
• W4313522493 cites W2037617087 @default.
• W4313522493 cites W2044431598 @default.
• W4313522493 cites W2047067243 @default.
• W4313522493 cites W2055650947 @default.
• W4313522493 cites W2062312459 @default.
• W4313522493 cites W2080261745 @default.
• W4313522493 cites W2145078756 @default.
• W4313522493 cites W2145688027 @default.
• W4313522493 cites W2324564321 @default.
• W4313522493 cites W2464310977 @default.
• W4313522493 cites W2564584078 @default.
• W4313522493 cites W2726992402 @default.
• W4313522493 cites W2893450414 @default.
• W4313522493 cites W2900226873 @default.
• W4313522493 cites W2901507442 @default.
• W4313522493 cites W2943793201 @default.
• W4313522493 cites W2947974641 @default.
• W4313522493 cites W2967028785 @default.
• W4313522493 cites W2969374678 @default.
• W4313522493 cites W2984000721 @default.
• W4313522493 cites W2991201894 @default.
• W4313522493 cites W2991232901 @default.
• W4313522493 cites W2991306778 @default.
• W4313522493 cites W2997794993 @default.
• W4313522493 cites W3023441565 @default.
• W4313522493 cites W3024458539 @default.
• W4313522493 cites W3027275233 @default.
• W4313522493 cites W3029137796 @default.
• W4313522493 cites W3044458118 @default.
• W4313522493 cites W3044858173 @default.
• W4313522493 cites W3107533236 @default.
• W4313522493 cites W3112187378 @default.
• W4313522493 cites W3145445624 @default.
• W4313522493 cites W3153471365 @default.
• W4313522493 cites W3186942822 @default.
• W4313522493 cites W3206955290 @default.
• W4313522493 cites W3213099553 @default.
• W4313522493 cites W3214388858 @default.
• W4313522493 cites W4210446308 @default.
• W4313522493 cites W4229022194 @default.
• W4313522493 cites W4245622808 @default.
• W4313522493 cites W4280622066 @default.
• W4313522493 cites W4281630788 @default.
• W4313522493 doi "https://doi.org/10.1186/s12951-022-01759-1" @default.
• W4313522493 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36597067" @default.
• W4313522493 hasPublicationYear "2023" @default.
• W4313522493 type Work @default.
• W4313522493 citedByCount "4" @default.
• W4313522493 countsByYear W43135224932023 @default.
• W4313522493 crossrefType "journal-article" @default.
• W4313522493 hasAuthorship W4313522493A5001154049 @default.
• W4313522493 hasAuthorship W4313522493A5003559708 @default.
• W4313522493 hasAuthorship W4313522493A5005054655 @default.
• W4313522493 hasAuthorship W4313522493A5005792080 @default.
• W4313522493 hasAuthorship W4313522493A5007788604 @default.
• W4313522493 hasAuthorship W4313522493A5011272577 @default.
• W4313522493 hasAuthorship W4313522493A5024942897 @default.
• W4313522493 hasAuthorship W4313522493A5025085123 @default.
• W4313522493 hasAuthorship W4313522493A5033334352 @default.
• W4313522493 hasAuthorship W4313522493A5064008773 @default.
• W4313522493 hasAuthorship W4313522493A5070917604 @default.
• W4313522493 hasAuthorship W4313522493A5078841336 @default.
• W4313522493 hasAuthorship W4313522493A5082093262 @default.
• W4313522493 hasAuthorship W4313522493A5083397911 @default.
• W4313522493 hasAuthorship W4313522493A5084685429 @default.
• W4313522493 hasBestOaLocation W43135224931 @default.
• W4313522493 hasConcept C105702510 @default.
• W4313522493 hasConcept C121608353 @default.
• W4313522493 hasConcept C12554922 @default.
• W4313522493 hasConcept C126322002 @default.
• W4313522493 hasConcept C1491633281 @default.
• W4313522493 hasConcept C155672457 @default.
• W4313522493 hasConcept C16387964 @default.
• W4313522493 hasConcept C171250308 @default.
• W4313522493 hasConcept C182606246 @default.
• W4313522493 hasConcept C185592680 @default.

• next